Los puntos clave no están disponibles para este artículo en este momento.
THE DISCOVERY that simian virus 40 (SV40) is oncogenic for certain newborn laboratory animals has raised the question of its carcinogenicity in man, particularly since this agent has been found in poliomyelitis and adenovirus vaccines. It is estimated that live SV40 has been injected into and ingested by hundreds of thousands, if not millions, of vaccines.1Although clinical disease has not been reported, SV40 has low infectivity in man when administered by mouth with attenuated poliovirus vaccine1and by the respiratory route.2From the evidence presently available, however, it appears that the largest source ofpotentialhuman infectivity by SV40 in the US was formalinized poliomyelitis vaccine containing the simian agent administered subcutaneously.3The purpose of this report is to present a brief review of the literature and an epidemiologic study bearing on this problem. Review of Literature In 1960 Sweet and Hilleman4reported the
Joseph F. Fraumeni (Sat,) studied this question.